←
BARDA3,053 posts
BARDA avatar

BARDA

@BARDA

Advancing countermeasures against 21st century health threats by bringing together public private partnerships and advancing innovation. Part of HHS/ASPR.

◷ Joined April 2017▧ 2,020 Photos and videos
BARDA avatar
BARDA@BARDA·Oct 19

The newly updated Chemical Hazards Emergency Medical Management (CHEMM) is now available! Built for #EMS, hospitals, poison centers, and #PublicHealth professionals, it offers quick guidance for chemical emergency preparedness and response. Check it out: ow.ly/yHkG50ZZ0AU

0:48
BARDA avatar
BARDA@BARDA·Sep 1

We’re developing FloPredict, an AI algorithm that analyzes Doppler signals from @Flosonics's FloPatch, an FDA-cleared wearable ultrasound device. It may enable faster identification and triage of patients at risk for complications from internal hemorrhage: ow.ly/R3jB50ZHxxg

Post attachment
BARDA avatar
BARDA@BARDA·Aug 26

BARDA & VITAL – a BAN Hub – announced 9 Concept Stage winners in the SMART Antiviral Prize Competition and a $50 million addition to this initiative to support development of antiviral drugs to treat multiple Flaviviridae & Togaviridae viruses. 🔗: ow.ly/Iz5Y50ZFCN0

Post attachmentPost attachmentPost attachment
BARDA avatar
BARDA@BARDA·Aug 18

Seeking proposals to ensure the nation is prepared for the next influenza pandemic. These partnerships will support @US_FDA-licensed manufacturing of influenza antigens & adjuvants and ensure vaccine capacity is available when needed. Proposals due 10/30: ow.ly/k3jL50ZAZfm

Post attachment
BARDA avatar
BARDA@BARDA·Jul 22

In a large-scale burn mass casualty incident, having fast & accurate wound imaging tools is crucial to improving patient outcomes. This De Novo-cleared system has the potential to optimize the use of limited burn care resources and enable timely triage & transfer to burn centers.

BARDA avatar
BARDA@BARDA·Jul 22

The DeepView AI-Burn System from our partner @Spectral_MDAI is the most recent BARDA-supported burn product to receive FDA approval, licensure or clearance. ️This AI-enabled software is used on Spectral AI’s imaging device to assess the size & healing potential of a burn wound.

Post attachment
BARDA avatar
BARDA@BARDA·Jun 15

Under Project BioShield, we're partnering w/ @VericelCorp to ensure access to FDA-licensed NexoBrid during a disaster. Vericel will manage product storage to guarantee availability & reduce costs, and further develop NexoBrid to treat blast injuries. medicalcountermeasures.gov/b…

Post attachment
HHS ASPR avatar
⟳ BARDA retweeted
HHS ASPR@ASPRgov·Jun 11

Building domestic manufacturing capacity, BARDA and Schott inaugurated a new production line for production of pharmaceutical glass vials at their facility in Lebanon, PA. Thanks to a longstanding partnership between @BARDA and Schott Pharma, the new production lines, once complete, will be used to make up to 140 million additional 2R vials annually and will support rapid scale production and delivery of medical countermeasures during emergencies.

Post attachmentPost attachmentPost attachmentPost attachment
BARDA avatar
BARDA@BARDA·Jun 9

We awarded a Project BioShield contract to @AVITAMedical for RECELL, an FDA-approved autograft-sparing device that uses a small sample of a patient’s own skin to treat full-thickness burns & trauma, enhancing readiness for radiological & nuclear incidents: ow.ly/AA7Z50Z9mT2

Post attachment
BARDA avatar
BARDA@BARDA·Apr 30

BARDA awarded a new Project BioShield contract to @ShionogiUS to enhance nat'l preparedness for biothreats and multidrug-resistant infections while expanding manufacturing to domestic facilities to build stronger defenses against future health emergencies: ow.ly/Uz1550YRbL1

Post attachment
BARDA avatar
BARDA@BARDA·Apr 28

This rapid diagnostic can help determine if a patient’s acute respiratory infection is caused by a bacterial infection. It can also help inform treatment decisions and reduce unnecessary antibiotic use, which has the potential to improve #AntibioticStewardship. ⬇️

BARDA avatar
BARDA@BARDA·Apr 28

The FebriDx Bacterial/Non-bacterial Assay from @LumosDX is the 110th BARDA-supported product to receive @US_FDA approval, licensure or clearance. The 510(k) clearance & CLIA-waiver expands use of the test in settings like doctor’s offices, pharmacies, etc. ⬇️

Post attachment